Edwards Lifesciences (EW) Retained Earnings (2009 - 2026)

Edwards Lifesciences' Retained Earnings history runs 18 years deep, the most recent figure standing at -$221.3 million for Q1 2026.

• In Q1 2026, Retained Earnings rose 13.05% year-over-year to -$221.3 million; the TTM figure through Mar 2026 stood at -$221.3 million (up 13.05% YoY), while the FY2025 annual figure was $14.2 billion, up 8.15% from the prior year.
• Retained Earnings was -$221.3 million for Q1 2026 at Edwards Lifesciences, down from $14.2 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $14.2 billion in Q4 2025 to a low of -$254.5 million in Q1 2025.
• Historically, Retained Earnings has averaged $6.8 billion across 5 years, with a median of $7.6 billion in 2022.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings tumbled 102.94% in 2024, then surged 6393.46% in 2025.
• A 5-year view of Retained Earnings shows it stood at $7.6 billion in 2022, then increased by 18.48% to $9.0 billion in 2023, then jumped by 46.42% to $13.2 billion in 2024, then climbed by 8.15% to $14.2 billion in 2025, then slumped by 101.55% to -$221.3 million in 2026.
• The last three Retained Earnings figures came in at -$221.3 million (Q1 2026), $14.2 billion (Q4 2025), and $14.1 billion (Q3 2025), per Business Quant data.